Next Article in Journal
Live Cell Microscopy of Murine Polyomavirus Subnuclear Replication Centers
Next Article in Special Issue
Viral Related Tools against SARS-CoV-2
Previous Article in Journal
Characterization of a DCL2-Insensitive Tomato Bushy Stunt Virus Isolate Infecting Arabidopsis thaliana
Previous Article in Special Issue
Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology
Article

Parenterally Administered Porcine Epidemic Diarrhea Virus-Like Particle-Based Vaccine Formulated with CCL25/28 Chemokines Induces Systemic and Mucosal Immune Protectivity in Pigs

1
Graduate Institute of Molecular and Comparative Pathobiology, School of Veterinary Medicine, National Taiwan University, Taipei 106, Taiwan
2
Department of Bioscience Technology, Chung Yuan Christian University, Taoyuan 320, Taiwan
3
Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 406, Taiwan
*
Authors to whom correspondence should be addressed.
Viruses 2020, 12(10), 1122; https://doi.org/10.3390/v12101122
Received: 23 July 2020 / Revised: 30 September 2020 / Accepted: 30 September 2020 / Published: 2 October 2020
(This article belongs to the Special Issue The Application of Viruses to Biotechnology)
Generation of a safe, economical, and effective vaccine capable of inducing mucosal immunity is critical for the development of vaccines against enteric viral diseases. In the current study, virus-like particles (VLPs) containing the spike (S), membrane (M), and envelope (E) structural proteins of porcine epidemic diarrhea virus (PEDV) expressed by the novel polycistronic baculovirus expression vector were generated. The immunogenicity and protective efficacy of the PEDV VLPs formulated with or without mucosal adjuvants of CCL25 and CCL28 (CCL25/28) were evaluated in post-weaning pigs. While pigs intramuscularly immunized with VLPs alone were capable of eliciting systemic anti-PEDV S-specific IgG and cellular immunity, co-administration of PEDV VLPs with CCL25/28 could further modulate the immune responses by enhancing systemic anti-PEDV S-specific IgG, mucosal IgA, and cellular immunity. Upon challenge with PEDV, both VLP-immunized groups showed milder clinical signs with reduced fecal viral shedding as compared to the control group. Furthermore, pigs immunized with VLPs adjuvanted with CCL25/28 showed superior immune protection against PEDV. Our results suggest that VLPs formulated with CCL25/28 may serve as a potential PEDV vaccine candidate and the same strategy may serve as a platform for the development of other enteric viral vaccines. View Full-Text
Keywords: porcine epidemic diarrhea virus; VLP; chemokines; pig; vaccine porcine epidemic diarrhea virus; VLP; chemokines; pig; vaccine
Show Figures

Figure 1

MDPI and ACS Style

Hsu, C.-W.; Chang, M.-H.; Chang, H.-W.; Wu, T.-Y.; Chang, Y.-C. Parenterally Administered Porcine Epidemic Diarrhea Virus-Like Particle-Based Vaccine Formulated with CCL25/28 Chemokines Induces Systemic and Mucosal Immune Protectivity in Pigs. Viruses 2020, 12, 1122. https://doi.org/10.3390/v12101122

AMA Style

Hsu C-W, Chang M-H, Chang H-W, Wu T-Y, Chang Y-C. Parenterally Administered Porcine Epidemic Diarrhea Virus-Like Particle-Based Vaccine Formulated with CCL25/28 Chemokines Induces Systemic and Mucosal Immune Protectivity in Pigs. Viruses. 2020; 12(10):1122. https://doi.org/10.3390/v12101122

Chicago/Turabian Style

Hsu, Chin-Wei, Ming-Hao Chang, Hui-Wen Chang, Tzong-Yuan Wu, and Yen-Chen Chang. 2020. "Parenterally Administered Porcine Epidemic Diarrhea Virus-Like Particle-Based Vaccine Formulated with CCL25/28 Chemokines Induces Systemic and Mucosal Immune Protectivity in Pigs" Viruses 12, no. 10: 1122. https://doi.org/10.3390/v12101122

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop